Nice study that harnesses big data insights and comprehensive experimentation to identify a novel, druggable kinase upregulation based mechanism tempering chromosome instability in therapy resistant metastatic bit.ly/3yw7eCC #prostatecancer Veronica R Bravo Cell Reports Medicine

Truly a remarkable example!😉

Are fibroblasts a potentially overlooked cell therapy option?

Important to remember.

Lynx Dx: Improving Patient Care By Predicting Risks Of Clinically Significant Prostate Cancer In A $3 Billion Market dlvr.it/T71ZHX #Innovation #Profiles #LynxDx

Interesting new technology in the #prostatecancer diagnostics space.

Using microRNAs for potential early diagnosis of #PancreaticCancer, which can make a significant difference in outcomes.

Short but interesting piece in pharmaphorum on the role of sequencing technologies in early #cancer diagnosis and treatment. pharmaphorum.com/rd/short-reads…

Given recent news on biopharma radioisotope shortages, some timely reporting from Anna Brown on funding to strengthen production capabilities. endpts.com/itm-nabs-e188m… #radiopharma

False positives, cost-benefit questions and a slow pace of regulatory approval are creating issues for multi-cancer detection tests.

The number of old-school taxonomists has seemingly been in decline for decades, but Robert Langellier makes a solid case for why this decline needs to be reversed. nytimes.com/2024/07/07/opi…

Bicara Therapeutics and Zenas Biopharma have provided fresh impetus to the IPO market with filings that illustrate what newly public biotechs may look like in the back half of 2024. fiercebiotech.com/biotech/bicara…

Really nice summary of the history of therapeutic development in Alzheimer’s. Are vaccines the new frontier of treatment? From Graham Lawton. newscientist.com/article/mg2633…

Wave Life Sciences rides new Phase 2 DMD data as it sets sights on accelerated approval 🌊 $WVE w/ Max Bayer endpts.com/wave-rides-new…

New indication for Dupixent

From Jasmin Fox-Skelly, an interesting article on the potential role of versatile microglial cells in the brain on neuroinflammation and disease. bbc.com/future/article…

Interesting review of the continuing development of RNA editing as a potential therapeutic tool.

The bad news continues for 23andMe.

A comprehensive article on the challenges for genetic medicine companies from Jason Mast . In spite of some scientific progress, financial woes are commonplace. Will the business model work? statnews.com/2025/02/06/cri….